Stock listing
NASDAQ:DRRX Durect Corporation Stock
Follow Durect Corporation into a list and get an email when it puts out news.
Last close · NASDAQ:DRRX
$1.91 USD
Close on Sep 10, 2025 · No longer trades
- Lowest – highest close
- $0.50 – $8.72 USDSince Dec 6, 2022 · lowest May 27, 2025 · highest Jan 17, 2023
Delisted NASDAQ:DRRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DRRX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Durect Corporation on 6ix
- Calls
- 14 calls with a replay · 14 with a transcript · latest Mar 26, 2025
- Decks
- 3 decks · latest Nov 7, 2023
Events
| Call | When | Status |
|---|---|---|
| DURECT (DRRX) Q4 2024 Earnings Call | Wed, Mar 26, 2025 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q2 2024 Earnings Call | Tue, Aug 13, 2024 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q1 2024 Earnings Call | Mon, May 13, 2024 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q4 2023 Earnings Call | Wed, Mar 27, 2024 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q3 2023 Earnings Call | Mon, Nov 13, 2023 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q2 2023 Earnings Call | Wed, Aug 09, 2023 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q1 2023 Earnings Call | Mon, May 08, 2023 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q4 2022 Earnings Call | Tue, Mar 07, 2023 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q3 2022 Earnings Call | Wed, Nov 02, 2022 · 4:30 PM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| DURECT (DRRX) Q2 2022 Earnings Call | Thu, Aug 04, 2022 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q1 2022 Earnings Call | Wed, May 04, 2022 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q4 2020 Earnings Call | Wed, Apr 21, 2021 · 4:30 PM ET | Replay |
| DURECT (DRRX) Q3 2020 Earnings Call | Mon, Nov 02, 2020 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (November 2023) | Technical | 15 slides | Nov 7, 2023 |
| Investor Presentation (May 2023) | Investor deck | 53 slides | May 16, 2023 |
| Investor Presentation (February 2023) | Investor deck | 27 slides | Feb 3, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jay P. Shepard Other companies: Ironwood Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 15, 2020); Esperion Therapeutics, Inc. (Director · Since at least May 24, 2018); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Jan 17, 2017 · Past); Aravive Inc (Director · Mar 20, 2014 – Jan 9, 2020 · Past) | Director · Sep 26, 2013 – Jun 22, 2016 · Past |
| Gail M Farfel Other companies: ProMIS Neurosciences Inc. (Chief Executive Officer, Director · Sep 19, 2022 – Aug 23, 2023 · Past); Tectonic Therapeutic, Inc. (Director · Jun 8, 2022 – Jun 6, 2023 · Past) | Director · Since at least May 9, 2022 |
| Armand Neukermans | Director · Jun 19, 2018 – Jun 17, 2020 · Past |
| Judith J Robertson | Director · Since at least Apr 23, 2019 |
| Judy R Joice | Sr. VP Operations & Corp QA · Mar 28, 2014 – Feb 21, 2023 · Past |
| Li Jian | InterimPrincipalAccountingOfcr · Mar 17, 2022 – Mar 17, 2022 · Past |
| Matthew J Hogan | Chief Financial Officer · Jan 27, 2009 – Jan 26, 2018 · Past |
| Norman Sussman | Chief Medical Officer · Since at least Nov 2, 2020 |
| Timothy M Papp | Chief Financial Officer · Since at least Jul 1, 2022 |
Log in to ask 6ix AI your own questions about Durect Corporation.